View in EDS

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Saved in:
Bibliographic Details
Title: Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.
Authors: Lukic T; Pfizer Inc, New York, NY, USA., Ghosh P; Pfizer Inc, Cambridge, MA, USA., Napatalung L; Pfizer Inc, New York, NY, USA.; Mount Sinai Hospital, New York, NY, USA., Wang C; Pfizer Inc, Groton, CT, USA., Kurosky SK; Pfizer Inc, New York, NY, USA., Hamzavi I; Henry Ford Health, Detroit, MI, USA., Sinclair R; University of Melbourne, Melbourne, VIC, Australia.; Sinclair Dermatology, East Melbourne, VIC, Australia., Xiang L; Huashan Hospital, Fudan University, Shanghai, China., Steil K; CCT Research, Scottsdale, AZ, USA.; University of Arizona, Phoenix, AZ, USA., Rosmarin D; Indiana University School of Medicine, Indianapolis, IN, USA., Parsad D; Postgraduate Institute of Medical Education and Research, Chandigarh, India., Ezzedine K; Université Paris-Est Créteil, Créteil, France.; Henri-Mondor University Hospital, Créteil, France., Adiri R; Pfizer Pharmaceutical Israel Ltd, Arye Shenkar St 9, 4672509, Herzliya, Israel. Roni.Adiri@pfizer.com.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jul; Vol. 16 (7), pp. 3709-3727. Date of Electronic Publication: 2026 May 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42171987
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lukic+T%22">Lukic T</searchLink>; Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ghosh+P%22">Ghosh P</searchLink>; Pfizer Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Napatalung+L%22">Napatalung L</searchLink>; Pfizer Inc, New York, NY, USA.; Mount Sinai Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Pfizer Inc, Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Kurosky+SK%22">Kurosky SK</searchLink>; Pfizer Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hamzavi+I%22">Hamzavi I</searchLink>; Henry Ford Health, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Sinclair+R%22">Sinclair R</searchLink>; University of Melbourne, Melbourne, VIC, Australia.; Sinclair Dermatology, East Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Xiang+L%22">Xiang L</searchLink>; Huashan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Steil+K%22">Steil K</searchLink>; CCT Research, Scottsdale, AZ, USA.; University of Arizona, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Rosmarin+D%22">Rosmarin D</searchLink>; Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Parsad+D%22">Parsad D</searchLink>; Postgraduate Institute of Medical Education and Research, Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22Ezzedine+K%22">Ezzedine K</searchLink>; Université Paris-Est Créteil, Créteil, France.; Henri-Mondor University Hospital, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Adiri+R%22">Adiri R</searchLink>; Pfizer Pharmaceutical Israel Ltd, Arye Shenkar St 9, 4672509, Herzliya, Israel. Roni.Adiri@pfizer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2026 Jul; Vol. 16 (7), pp. 3709-3727. <i>Date of Electronic Publication: </i>2026 May 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42171987
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-026-01724-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3709
    Titles:
      – TitleFull: Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lukic T
      – PersonEntity:
          Name:
            NameFull: Ghosh P
      – PersonEntity:
          Name:
            NameFull: Napatalung L
      – PersonEntity:
          Name:
            NameFull: Wang C
      – PersonEntity:
          Name:
            NameFull: Kurosky SK
      – PersonEntity:
          Name:
            NameFull: Hamzavi I
      – PersonEntity:
          Name:
            NameFull: Sinclair R
      – PersonEntity:
          Name:
            NameFull: Xiang L
      – PersonEntity:
          Name:
            NameFull: Steil K
      – PersonEntity:
          Name:
            NameFull: Rosmarin D
      – PersonEntity:
          Name:
            NameFull: Parsad D
      – PersonEntity:
          Name:
            NameFull: Ezzedine K
      – PersonEntity:
          Name:
            NameFull: Adiri R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2193-8210
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Dermatology and therapy
              Type: main
ResultId 1